Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
Global funding for biomedical research now approaches $270 billion per year, nearly two-thirds of which comes from industry, including pharmaceutical, biotechnology, and medical device companies.1 While industry’s investment in research has spawned breakthroughs and innovations, these investments have also fueled concerns that industry-funded clinical trials are more likely to have proindustry conclusions,2 potentially distorting the evidence base to favor more expensive, brand name products on which manufacturers continue to spend research dollars.
Ross JS. It’s Not Just About the Money, Money, Money…. JAMA Intern Med. 2014;174(10):1696. doi:10.1001/jamainternmed.2014.3374